Cancer Family

Reproductive System Neoplasm

Non-malignant3,042 active trials38 approved drugs197 evidence items

NCIt: C3674

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (625)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 101–125 of 625 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Theranostics in the management of prostate cancer: from concept to clinical practice.
Kannan Sridharan, Teresa Alonso-Gordoa, Gowri Sivaramakrishnan et al. · Expert Rev Clin Pharmacol · Sep 29, 2026 · PMID 42770599 · candidate dictionary pubmed
STC2 promotes cisplatin resistance through metabolic reprogramming and lactylation-mediated epigenetic regulation in cervical cancer.
Shanshan Jin, Dongqin Gao, Yaling Xiahou et al. · Acta Biochim Biophys Sin (Shanghai) · Sep 29, 2026 · PMID 42809369 · candidate dictionary pubmed
Letter to the editor on "Cervical cancer incidence and mortality trends in China: The role of screening".
Xintong Huang, Thomas Santo · Cancer Lett · Sep 28, 2026 · PMID 42250755 · candidate dictionary pubmed
Inhibition of Translesion DNA Synthesis Sensitizes BRCA-Deficient Ovarian Cancer to PARP Inhibitors.
Na Li, Kousalya Lavudi, Qianyun Ge et al. · Cancer Res · Sep 28, 2026 · PMID 42804161 · candidate dictionary pubmed
[Update on ovarian cancer].
Pauline Wimberger, Theresa Link · Pathologie (Heidelb) · Sep 28, 2026 · PMID 42803933 · candidate dictionary pubmed
Pattern of ovarian cancer recurrence and survival: final analysis of an extended cohort of 591 patients.
Edgar Petru, Katharina Eberhard, Haro Stettner et al. · Wien Med Wochenschr · Sep 28, 2026 · PMID 42803900 · candidate dictionary pubmed
Sensitizing nanomedicine for platinum-resistant ovarian cancer.

Diana Hsin-Yu Lee, William Lee, Horacio Bach · Nanomedicine (Lond) · Sep 28, 2026 · PMID 42802703 · candidate dictionary pubmed

Cardiovascular Risk Triage Schema for Patients With Prostate Cancer Treated With Hormone Therapy.

Avirup Guha, Ana Barac, Michael James Ryan et al. · JCO Oncol Pract · Sep 28, 2026 · PMID 42804714 · candidate dictionary pubmed

Prostate Cancer Screening and Likelihood of Benefit in Veterans Affairs and Fee-for-Service Medicare.

Alex K Bryant, Adam VanDeusen, Mandi L Klamerus et al. · JAMA Intern Med · Sep 28, 2026 · PMID 42804174 · candidate dictionary pubmed

Does Positive Margin in Secondary Tumors at Radical Prostatectomy Predict Biochemical Recurrence in Multifocal Prostate Cancer?

Nikunj B Shah, Angelica Menendez, Sanoj Punnen et al. · Am J Surg Pathol · Sep 28, 2026 · PMID 42802667 · candidate dictionary pubmed

Stage migration in prostate cancer: the role of PSMA-PET in identifying oligometastatic disease.

Francesco Mattana, Stefano Luzzago, Valentino Dragonetti et al. · Eur J Nucl Med Mol Imaging · Sep 28, 2026 · PMID 42802268 · candidate dictionary pubmed

Spotlights on Cervical Cancer: Progression, Diagnosis and Clinical Manifestations, Epidemiology, Treatment Approaches, Role of Artificial Intelligence and Future Directions.

Hesham M Tawfeek, Ahmed A H Abddelatif, Hassan Barakat · Drug Dev Ind Pharm · Sep 28, 2026 · PMID 42803760 · candidate dictionary pubmed

Clinical and MRI characteristics of germline pathogenic variant carriers diagnosed with prostate cancer.

Rory L Cochran, Madhangi Parameswaran, Nabih Nakrour et al. · Eur Radiol · Sep 28, 2026 · PMID 42806037 · candidate dictionary pubmed

Temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggest a window of opportunity for checkpoint inhibitor therapy in prostate cancer.

Anmbreen Jamroze, Renyuan Zhang, Emily Dougherty et al. · J Immunother Cancer · Sep 28, 2026 · PMID 42805760 · candidate dictionary pubmed

Differential Association of Post-Testosterone Recovery PSA Kinetics with Progression and Metastatic Outcomes in Non-metastatic Prostate Cancer.

Samuel Lichtman-Mikol, Serageldin Kamel Attia, Yilun Sun et al. · Int J Radiat Oncol Biol Phys · Sep 28, 2026 · PMID 42805409 · candidate dictionary pubmed

Diagnostic performance of 29-MHz micro-ultrasound using cognitive fusion with multiparametric MRI for the detection of clinically significant prostate cancer: a single-center retrospective study.

Cedric Idri, Floriane Michel, Michel Soulie et al. · Fr J Urol · Sep 28, 2026 · PMID 42805393 · candidate dictionary pubmed

Integrated reverse network toxicology and experimental validation identify PTP4A3 as a key target of Benzo[a]pyrene in prostate cancer.

Shiwang Yuan, Jiang Shi, Lin Jiang et al. · Chem Biol Interact · Sep 28, 2026 · PMID 42805285 · candidate dictionary pubmed

Language as a powerful "Influencer" in Prostate Cancer.

Adam B Weiner, Jessica Rett, Scott E Eggener · J Urol · Sep 28, 2026 · PMID 42804927 · candidate dictionary pubmed

FEBE: The female brachytherapy experience. Assessing PTSD symptom rates in women treated for locally advanced cervical cancer with HDR brachytherapy.

Raksha M Narasimhan, Monica Wassel, Emma Herbach et al. · Brachytherapy · Sep 28, 2026 · PMID 42805882 · candidate dictionary pubmed

Modulation of intracellular heme metabolism enhances artesunate-induced cytotoxicity in CD44v-positive cervical cancer cells.

Yoko Ueda, Mieko Tsuji, Minako Mori et al. · Free Radic Biol Med · Sep 28, 2026 · PMID 42805425 · candidate dictionary pubmed

Real-World Landscape of BRCA Deleterious Alterations in Advanced Prostate Cancer: Insights From a Nationwide Genomic Database.

Hideyasu Tsumura, Dai Koguchi, Ken-Ichi Tabata et al. · Prostate · Sep 27, 2026 · PMID 42801735 · candidate dictionary pubmed

NCCN Risk Groups Do Not Predict Adverse Pathology or Oncologic Outcomes Among Patients With Grade Group 1 Prostate Cancer in the MRI Era.

Eric V Li, Tae-Hee Kim, Michael K Wang et al. · Prostate · Sep 27, 2026 · PMID 42801734 · candidate dictionary pubmed

Is a Few Too Many? Alcohol Consumption and Prostate Cancer Upgrading During Active Surveillance.

Jack Campbell, Michelle I Higgins, Zhuo Tony Su et al. · Prostate · Sep 27, 2026 · PMID 42801731 · candidate dictionary pubmed

Androgen Receptor-Immune Crosstalk in Metastatic Castration-Resistant Prostate Cancer: From Context-Dependent Remodeling to Biomarker-Guided Translation.

Linjie Li, Ruixi Feng, Bingyang Zha et al. · Prostate · Sep 27, 2026 · PMID 42801730 · candidate dictionary pubmed

Insulin-Like Growth Factor Axis and Survival in Metastatic Hormone-Sensitive Prostate Cancer: Post-Hoc Analysis From the ENZAMET Phase 3 Trial.

Michael A Cilento, Hui-Ming Lin, Nicole Yeung et al. · Prostate · Sep 27, 2026 · PMID 42801727 · candidate dictionary pubmed